Medical Device Clinical Trials Less Mature Than Drug Trials
This article was originally published in PharmAsia News
Executive SummaryWith the release of new laws and regulations for drug clinical trials in China, national drug clinical trials have matured accordingly, while the development of medical device trials lags behind
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.